Abstract
This study aimed to prepare tamsulosin hydrochloride (HCl)-loaded in situ gelling formulation by using hydroxypropyl methylcellulose (HPMC), gellan gum, poloxamer 188, and benzalkonium chloride. Physicochemical evaluation of formulations included determination of pH, viscosity, gelation time, gel strength, drug content, and sterility. In silico study was performed to analyze interactions between polymers, drug, and mucin glycoprotein. In vitro degradation time, drug release, ex vivo mucoadhesion time, permeation, in vivo pharmacokinetics, and stability studies were performed to assess the formulation. Formulations were transparent and displayed acceptable physicochemical attributes. Tamsulosin HCl and polymers interacted via non-covalent interactions. HPMC formed hydrogen bonds, hydrophobic and van der Waals interactions with mucin protein while the drug formed hydrogen bonds only. Gel formulation degraded in simulated nasal fluid within 24 h. In situ gelling formulation showed 83.8 ± 1.7% drug release and remained adhered to the mucosa for 24.5 ± 1 h. A higher (~ 1.85 times) drug permeation was recorded through mucosa within 6 h by in situ gelling formulation when compared to control counterparts (aqueous solution of drug and in situ gelling formulation without poloxamer 188). Nasal administration of tamsulosin HCl by using in situ gelling formulation led to a ~ 3.3 and ~ 3.5 times, respectively, higher Cmax (maximum plasma concentration) and AUCtotal (total area under the curve) than the orally administered aqueous solution. Relative bioavailability of drug delivered by nasal in situ gelling formulation was 3.5 times the oral counterpart. These results indicated that the prepared in situ gelling formulation can act as a promising candidate for systemic administration of tamsulosin HCl.
Graphical Abstract
Similar content being viewed by others
References
Awedew AF, Han H, Abbasi B, Abbasi-Kangevari M, Ahmed MB, Almidani O, et al. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the global burden of disease study 2019. Lancet Heal Longev. 2022;3:e754-76.
Dunn CJ, Matheson A, Faulds DM. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging. 2002;19:135–61.
O’Leary MP. Tamsulosin: current clinical experience. Urology. 2001;58:42–8.
Almehmady AM, Elsisi AM. Development, optimization, and evaluation of tamsulosin nanotransfersomes to enhance its permeation and bioavailability. J Drug Deliv Sci Technol. 2020;57:101667.
Bakhaidar RB, Hosny KM, Mahier IM, Rizq WY, Safhi AY, Bukhary DM, et al. Development and optimization of a tamsulosin nanostructured lipid carrier loaded with saw palmetto oil and pumpkin seed oil for treatment of benign prostatic hyperplasia. Drug Deliv. 2022;29:2579–91.
Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP. Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine. 2008;26:2225–33.
Bonferoni MC, Rossi S, Sandri G, Ferrari F, Gavini E, Rassu G, et al. Nanoemulsions for “nose-to-brain” drug delivery. Pharmaceutics. 2019;11:84.
Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm. 2008;358:285–91.
Aukema AAC, Mulder PGH, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol. 2005;115:1017–23.
Rathnam G, Narayanan N, Ilavarasan R. Carbopol-based gels for nasal delivery of progesterone. AAPS PharmSciTech. 2008;9:1078–82.
Rogol AD, Tkachenko N, Bryson N. NatestoTM, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men. Andrology. 2016;4:46–54.
Altuntaş E, Yener G. Formulation and evaluation of thermoreversible in situ nasal gels containing mometasone furoate for allergic rhinitis. AAPS PharmSciTech. 2017;18:2673–82.
Rao M, Agrawal DK, Shirsath C. Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson’s disease. Drug Dev Ind Pharm. 2016;43:142–50.
Touitou E, Illum L. Nasal drug delivery. Drug Deliv Transl Res. 2013;3:1–3.
Keller LA, Merkel O, Popp A. Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res. 2022;12:735–57.
Laffleur F, Bauer B. Progress in nasal drug delivery systems. Int J Pharm. 2021;607:120994.
Kolawole OM, Cook MT. In situ gelling drug delivery systems for topical drug delivery. Eur J Pharm Biopharm. 2023;184:36–49.
Asantewaa Y, Aylott J, Burley JC, Billa N, Roberts CJ. Correlating physicochemical properties of boronic acid-chitosan conjugates to glucose adsorption sensitivity. Pharmaceutics. 2013;5:69–80.
Ganguly S, Dash AK. A novel in situ gel for sustained drug delivery and targeting. Int J Pharm. 2004;276:83–92.
Moon HJ, Ko DY, Park MH, Joo MK, Jeong B. Temperature-responsive compounds as in situ gelling biomedical materials. Chem Soc Rev. 2012;41:4860–83.
Liu W, Zhang B, Lu WW, Li X, Zhu D, De Yao K, et al. A rapid temperature-responsive sol–gel reversible poly(N-isopropylacrylamide)-g-methylcellulose copolymer hydrogel. Biomaterials. 2004;25:3005–12.
Jeong B, Gutowska A. Lessons from nature: Stimuli-responsive polymers and their biomedical applications. Trends Biotechnol. 2002;20:305–11.
Khare P, Chogale MM, Kakade P, Patravale VB. Gellan gum–based in situ gelling ophthalmic nanosuspension of posaconazole. Drug Deliv Transl Res. 2022;12:2920–35.
Nayak AK, Hasnain MS, Pal K, Banerjee I, Pal D. Gum-based hydrogels in drug delivery. In: Pal K, Banerjee I, Sarkar P, Kim D, Deng W-P, Dubey NK, et al., editors. Biopolym. Formul. Biomed. Food Appl. 1st ed. Elsevier Inc.; 2020.
Liu S, Chen X, Zhang Y. Hydrogels and hydrogel composites for 3D and 4D printing applications. 1st ed. Sadasivuni KK, Deshmukh K, Almaadeed MA, editors. 3D 4D Print. Polym. Nanocomposite Mater. Process. Appl. Challenges. Elsevier Inc.; 2019.
Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv. 2008;14:507–15.
Yermak IM, Davydova VN, Volod’ko AV. Mucoadhesive marine polysaccharides. Mar Drugs. 2022;20:1–25.
Durgapal S, Rana M, Mukhopadhyay S, Rana AJ, Goswami L, Joshi S. Formulation and evaluation of in-situ nasal gel of montelukast sodium for the effective treatment of asthma. Int J Pharm Sci Res. 2018;9:2792–9.
Naik A, Nair H. Formulation and evaluation of thermosensitive biogels for nose to brain delivery of doxepin. Biomed Res Int. 2014;2014:1–11.
Karpagavalli L, Gopalasrsatheeskumar K, Narayanan N, Maheswaran A, Raj AI, Priya JH. Formulation and evaluation of zolpidem nasal in situ gel. World J Pharm Res. 2017;6:940–51.
Jagdale S, Shewale N, Kuchekar BS. Optimization of thermoreversible in situ nasal gel of timolol maleate. Scientifica (Cairo). 2016;2016:1–12.
Laddha UD, Kshirsagar SJ. Formulation of nanoparticles loaded in situ gel for treatment of dry eye disease: in vitro, ex vivo and in vivo evidences. J Drug Deliv Sci Technol. 2021;61:102112.
Kurniawansyah IS, Rusdiana T, Sopyan I, Ramoko H, Wahab HA, Subarnas A. In situ ophthalmic gel forming systems of poloxamer 407 and hydroxypropyl methyl cellulose mixtures for sustained ocular delivery of chloramphenicole: optimization study by factorial design. Heliyon. 2020;6:e05365.
Makwana SB, Patel VA, Parmar SJ. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results Pharma Sci. 2016;6:1–6.
Ruan X, Hu J, Lu L, Wang Y, Tang C, Liu F, et al. Poloxamer 407/188 binary thermosensitive gel as a moxidectin delivery system: in vitro release and in vivo evaluation. Molecules. 2022;27:1–11.
Baloglu E, Karavana SY, Senyigit ZA, Guneri T. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base. Pharm Dev Technol. 2011;16:627–36.
Fathalla ZMA, Vangala A, Longman M, Khaled KA, Hussein AK, El-Garhy OH, et al. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterisation, toxicity and transcorneal permeation studies. Eur J Pharm Biopharm. 2017;114:119–34.
Soliman KA, Ullah K, Shah A, Jones DS, Singh TRR. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications. Drug Discov Today. 2019;24:1575–86.
Pereira BMP, Tagkopoulos I. Benzalkonium chlorides: uses, regulatory status, and microbial resistance. Appl Environ Microbiol. 2019;85:1–13.
Galgatte UC, Kumbhar AB, Chaudhari PD. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation. Drug Deliv. 2014;21:62–73.
Al-Wiswasi NN, Al-Khedairy EBH. Formulation and in vitro evaluation of in-situ gelling liquid suppositories for naproxen. Iraqi J Pharm Sci. 2017;17:31–8.
Siddique MI, Katas H, Sarfraz M, Chohan TA, Jamil A, Mohd Amin MCI. Clinical insights into topically applied multipronged nanoparticles in subjects with atopic dermatitis. J Drug Deliv Sci Technol. 2021;65:102744.
Ahmad H, Ali Chohan T, Mudassir J, Mehta P, Yousef B, Zaman A, et al. Evaluation of sustained-release in-situ injectable gels, containing naproxen sodium, using in vitro, in silico and in vivo analysis. Int J Pharm. 2022;616:121512.
England RJA, Homer JJ, Knight LC, Ell SR. Nasal pH measurement: a reliable and repeatable parameter. Clin Otolaryngol Allied Sci. 1999;24:67–8.
Yu M, Yuan W, Li D, Schwendeman A, Schwendeman SP. Predicting drug release kinetics from nanocarriers inside dialysis bags. J Control Release. 2019;315:23–30.
Li T, Bao Q, Shen J, Lalla RV, Burgess DJ. Mucoadhesive in situ forming gel for oral mucositis pain control. Int J Pharm. 2020;580:119238.
Corazza E, di Cagno MP, Bauer-Brandl A, Abruzzo A, Cerchiara T, Bigucci F, et al. Drug delivery to the brain: in situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin. Eur J Pharm Sci. 2022;179:106294.
Jillani U, Mudassir J, Arshad MS, Mehta P, Alyassin Y, Nazari K, et al. Design and evaluation of agarose based buccal films containing zolmitriptan succinate: application of physical and chemical enhancement approaches. J Drug Deliv Sci Technol. 2022;69:103041.
Scutt G, Waxman D. Improved estimates of mean pharmacokinetic parameters for increased accuracy in dosing and reduced risk to patients. Br J Clin Pharmacol. 2021;87:3518–30.
Chughtai B, Forde JC, Thomas DDM, Laor L, Hossack T, Woo HH, et al. Benign prostatic hyperplasia. Nat Rev Dis Prim. 2016;2:1–15.
Author information
Authors and Affiliations
Contributions
SJR: investigation, formal analysis, writing—original draft. SZ: investigation, formal analysis, writing—original draft. AS: investigation, formal analysis, writing—original draft. MB: formal analysis, writing—original draft, writing—review and editing. JM: formal analysis, writing—original draft, writing—review and editing. MA: writing—original draft, writing—review and editing. TC: writing—original draft, writing—review and editing. MSA: conceptualization, writing—original draft, writing—review and editing.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rana, S.J., Zafar, S., Shahzad, A. et al. Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics. AAPS PharmSciTech 24, 242 (2023). https://doi.org/10.1208/s12249-023-02700-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-023-02700-x